Is Quince Therapeutics Inc (NASDAQ: QNCX) Worth What Its Shareholders Think It Is?
During the last session, Quince Therapeutics Inc (NASDAQ:QNCX)’s traded shares were 0.49 million, with the beta value of the company hitting 1.02. At the end
During the last session, Quince Therapeutics Inc (NASDAQ:QNCX)’s traded shares were 0.49 million, with the beta value of the company hitting 1.02. At the end
Quince Therapeutics Inc (NASDAQ:QNCX)’s traded shares stood at 0.14 million during the last session, with the company’s beta value hitting 1.02. At the close of
During the last session, Quince Therapeutics Inc (NASDAQ:QNCX)’s traded shares were 0.38 million, with the beta value of the company hitting 0.80. At the end
Quince Therapeutics Inc (NASDAQ:QNCX)’s traded shares stood at 0.65 million during the last session, with the company’s beta value hitting 0.81. At the close of
© 2024, Powered by Smart TechOne